Quest Diagnostics Total Non-Cash Items 2010-2025 | DGX

Quest Diagnostics annual/quarterly total non-cash items history and growth rate from 2010 to 2025. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
  • Quest Diagnostics total non-cash items for the quarter ending June 30, 2025 were $336M, a 38.84% increase year-over-year.
  • Quest Diagnostics total non-cash items for the twelve months ending June 30, 2025 were $1.507B, a 27.71% increase year-over-year.
  • Quest Diagnostics annual total non-cash items for 2024 were $0.599B, a 27.99% increase from 2023.
  • Quest Diagnostics annual total non-cash items for 2023 were $0.468B, a 9.65% decline from 2022.
  • Quest Diagnostics annual total non-cash items for 2022 were $0.518B, a 331.67% increase from 2021.
Quest Diagnostics Annual Total Non-Cash Items
(Millions of US $)
2024 $599
2023 $468
2022 $518
2021 $120
2020 $562
2019 $341
2018 $455
2017 $368
2016 $287
2015 $437
2014 $684
2013 $122
2012 $695
2011 $894
2010 $580
2009 $730
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.154B $9.872B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Encompass Health (EHC) United States $12.372B 24.71
DaVita (DVA) United States $10.036B 14.35
Elanco Animal Health (ELAN) United States $8.898B 19.90
Chemed (CHE) United States $6.689B 22.40
RadNet (RDNT) United States $5.392B 194.72
Option Care Health (OPCH) United States $4.664B 19.96
Addus HomeCare (ADUS) United States $2.180B 23.49
LifeStance Health (LFST) United States $2.159B 0.00
Astrana Health (ASTH) United States $1.720B 60.16
Aveanna Healthcare Holdings (AVAH) United States $1.560B 28.73
U.S Physical Therapy (USPH) United States $1.329B 33.24
Atai Life Sciences (ATAI) Germany $0.980B 0.00
Pennant (PNTG) United States $0.870B 30.69
Daxor (DXR) United States $0.053B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.050B 0.00
Psychemedics (PMD) United States $0.000B 0.00